Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Famciclovir 500 mg Comparing To Aciclovir 400mg in Patients With Herpes Zoster

NCT01327144 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT01327144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Famciclovir 500 mg Comparing To Aciclovir 400mg in Patients With Herpes Zoster
Lead sponsor
EMS
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
July 31, 2017
Enrollment
177 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster